Pharmas collaborating increasingly with universities. Novartis and the University of Pennsylvania announced a research and licensing agreement that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.
Roche vs. Novartis! Roche Holding AG will pay as much as $490 million for experimental drugs from PTC Therapeutics Inc. to treat a genetic muscle-weakening disease, in a deal that sets up a race with rival Novartis AG.
IBM and Novartis announced the NCD Challenge, a competition among a number of the world’s leading universities designed to tap the inventiveness of students to find new ways to address the rise of non-communicable diseases in both developing and developed countries.
Pfizer’s campaign to promote Lyrica is part of a stepped-up arms race among Western drug makers for a bigger presence in Japan, the world’s second-largest pharmaceuticals market after the U.S., with about $100 billion in yearly sales.